AGP Executive Report
Last update: 9 hours agoClinical AI for care delivery: Autonomize AI was named a 2026 World Economic Forum Technology Pioneer, positioning its “AI operating layer” to streamline fragmented US healthcare workflows. Women’s health and diagnosis: New ACOG guidance puts pain at the center of endometriosis care, allowing clinical diagnosis without surgical confirmation; separate reporting highlights how heart disease symptoms can be dismissed in women, especially when microvascular disease is missed. Healthcare integrity under scrutiny: Lucknow’s KGMU faces allegations of stents being forced for Ayushman Bharat funds, prompting a special inquiry panel to review stent records and medical necessity. Workforce pressure: Wales’ First Minister declined to guarantee jobs for student nurses, despite calls for a graduate employment promise. Menopause tracking tech: Apple’s Health app update will flag perimenopause based on cycle patterns and symptoms. Immunotherapy leadership: Cytospire appoints Samit Hirawat, M.D., to its board as it prepares CYT X300 for clinical trials. Research setbacks: Sanofi will stop the MOBILIZE phase 3 CIDP study for lack of sufficient efficacy, with no safety concerns flagged.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[A physician’s guide to making the most of a tax extension]]>](https://cdn.sanity.io/images/0vv8moc6/medec/1c01b854c9964e627c9ff5d6b337801d8e0425e7-1200x628.png)
